Alector Inc $ 10.8 -0.2 (-1.77%)
Warning! GuruFocus has detected 1 Severe warning sign with ALEC. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Alector Inc () from 2019 to Sep 30 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Alector stock (ALEC) PE ratio as of Sep 30 2020 is 0. More Details
Alector PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Alector PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:INSM NAS:KOD NAS:FATE NAS:AMRN NAS:DNLI NAS:ALKS NAS:APLS NAS:ICPT NYSE:ADCT NAS:NVAX OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Traded in other countries ALEC.USA
Address 131 Oyster Point Boulevard, Suite 600, South San Francisco, CA, USA, 94080
Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain.